Rafael Holdings, Inc. RFL
We take great care to ensure that the data presented and summarized in this overview for Rafael Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding RFL
View all-
Vanguard Group Inc Valley Forge, PA705KShares$1.32 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX338KShares$632,8560.0% of portfolio
-
Acuitas Investments, LLC282KShares$526,7020.26% of portfolio
-
Black Rock Inc. New York, NY204KShares$382,3850.0% of portfolio
-
Geode Capital Management, LLC Boston, MA148KShares$276,8870.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny70.5KShares$131,8910.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ52.7KShares$98,5500.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX51.7KShares$96,5960.0% of portfolio
-
Marquette Asset Management, LLC49.3KShares$92,1080.02% of portfolio
-
Cerity Partners LLC New York, NY46.4KShares$86,8220.0% of portfolio
Latest Institutional Activity in RFL
Top Purchases
Top Sells
About RFL
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Insider Transactions at RFL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 25
2024
|
William Conkling Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,431
-0.68%
|
$3,431
$1.84 P/Share
|
|
Oct 25
2024
|
David Polinsky Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,331
-2.2%
|
$3,331
$1.84 P/Share
|
|
Sep 23
2024
|
David Polinsky Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,431
-0.94%
|
$1,431
$1.73 P/Share
|
|
Sep 21
2024
|
David Polinsky Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,384
-1.54%
|
$2,384
$1.73 P/Share
|
|
Sep 21
2024
|
William Conkling Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,696
-2.44%
|
$12,696
$1.73 P/Share
|
|
Jul 24
2024
|
Howard S Jonas Executive Chairman |
BUY
Other acquisition or disposition
|
Indirect |
563,538
+50.0%
|
-
|
|
Jul 24
2024
|
Howard S Jonas Executive Chairman |
SELL
Other acquisition or disposition
|
Indirect |
563,538
-100.0%
|
-
|
|
Jun 26
2024
|
Howard S Jonas Executive Chairman |
BUY
Other acquisition or disposition
|
Indirect |
563,538
+50.0%
|
-
|
|
Jun 26
2024
|
Howard S Jonas Executive Chairman |
SELL
Other acquisition or disposition
|
Indirect |
563,538
-100.0%
|
-
|
|
Jun 21
2024
|
David Polinsky Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,296
-1.46%
|
$2,296
$1.46 P/Share
|
|
Jun 21
2024
|
William Conkling Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,295
-2.49%
|
$13,295
$1.46 P/Share
|
|
Jun 17
2024
|
Howard S Jonas Executive Chairman |
BUY
Other acquisition or disposition
|
Indirect |
187,427
+24.96%
|
-
|
|
Jun 17
2024
|
Howard S Jonas Executive Chairman |
SELL
Other acquisition or disposition
|
Direct |
187,427
-54.1%
|
-
|
|
Jun 14
2024
|
Howard S Jonas Executive Chairman |
BUY
Other acquisition or disposition
|
Indirect |
376,111
+50.0%
|
-
|
|
Jun 14
2024
|
Howard S Jonas Executive Chairman |
SELL
Other acquisition or disposition
|
Direct |
376,111
-52.05%
|
-
|
|
Jun 13
2024
|
Howard S Jonas Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
159,016
+18.04%
|
-
|
|
Apr 04
2024
|
Howard S Jonas Executive Chairman |
BUY
Other acquisition or disposition
|
Direct |
348,259
+38.19%
|
-
|
|
Apr 04
2024
|
Howard S Jonas Executive Chairman |
SELL
Other acquisition or disposition
|
Indirect |
348,259
-100.0%
|
-
|
|
Mar 21
2024
|
David Polinsky Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,300
-1.44%
|
$2,300
$1.7 P/Share
|
|
Mar 21
2024
|
William Conkling Chief Executive Officer |
BUY
Payment of exercise price or tax liability
|
Direct |
15,473
+2.82%
|
$15,473
$1.7 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 242K shares |
|---|---|
| Other acquisition or disposition | 2.39M shares |
| Payment of exercise price or tax liability | 29.1K shares |
| Other acquisition or disposition | 2.39M shares |
|---|---|
| Payment of exercise price or tax liability | 49.7K shares |